Plerixafor for Stem Cell Mobilization in Normal Donors

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Blood And Marrow Transplantation
Interventions
DRUG

Filgrastim

5 µg/kg in the morning daily for 4 days.

DRUG

Plerixafor

240 µg/kg subcutaneously in the evening on the fourth day of Filgrastim mobilization.

PROCEDURE

Apheresis Procedure

"The apheresis procedure will start in the morning of day 5, approximately 10 to 11 hours after the administration of Plerixafor.~The apheresis procedure may continue beyond day 1 until the target dose of 4x106 CD34+ cells/kg (recipient's weight) is obtained."

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Proteonomix, Inc.

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT01818284 - Plerixafor for Stem Cell Mobilization in Normal Donors | Biotech Hunter | Biotech Hunter